Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer

Published:2020-10-02 Issue:40 Volume:99 Page:e22203
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Zhang Yi,Wang Yuzhi,Tian Gang,Jiang Tianhua

Funder

Luzhou-Southwest Medical University applied basic research project

doctor of medicine start-up capital of the Affiliated Hospital of Southwest Medical University

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference35 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA,2018

2. Breast cancer management: quality-of-life and cost considerations;Radice;Pharmacoeconomics,2003

3. Dual promoter usage as regulatory mechanism of let-7c expression in leukemic and solid tumors;Pelosi;Mol Cancer Res,2014

4. Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities;Jiralerspong;J Clin Oncol,2016

5. A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinoma;Ni;Ann Surg Oncol,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of stable ferroptosis‐ and pyroptosis‐related signatures in predicting prognosis and immune status in breast cancer;Journal of Cellular and Molecular Medicine;2023-10-18

2. Emerging Role of Ferroptosis in Breast Cancer: Characteristics, Therapy, and Translational Implications for the Present and Future;Current Molecular Medicine;2023-09-13

3. Identification of A Six Immune-Related Genes Prognostic Signature and Exploration of Individual Therapies in Young Women with Cervical Cancer;2022-08-19

4. Epigenetic Regulation in Exposome-Induced Tumorigenesis: Emerging Roles of ncRNAs;Biomolecules;2022-03-28

5. The role of ferroptosis in breast cancer patients: a comprehensive analysis;Cell Death Discovery;2021-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3